Lecanemab is the first fda-approved treatment for Alzheimer's disease. Dr. Jason Karlawish, co-director of the Penn Memory Center, discusses the exciting potential of this leading edge drug, which resulted in part from breakthrough research led by Penn Medicine's Virginia Lee, PhD. #alzheimers #dementia #memoryloss #alzheimerstreatment